About this trial
This virtual randomized controlled trial evaluates the efficacy of a prebiotic and probiotic supplement in providing relief from symptoms associated with bacterial vaginosis and yeast infections. Participants will be randomized into three groups-test product, active placebo, and excipient placebo-and will take two capsules daily for 30 days. The study will assess the effects on vaginal microbiome, symptoms of bacterial vaginosis and yeast infections, and overall vaginal health.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women
Age 25+
Self-reported concerns symptoms associated with bacterial vaginosis or candida overgrowth, including itchiness, redness, abnormal discharge, and an unpleasant odor.
Suffers from digestive issues, including bloating, gas, or other digestive discomfort.
Disqualifiers
Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
Planning to undergo any procedure related to their vaginal health.
Started any new medications or supplements that target vaginal health in the past 3 months.
Anyone with known severe allergic reactions that require the use of an Epi-Pen, or any known allergies to any of the product ingredients
Trial design
Parallel
Treatments tested in this trial
Prebiotic + Probiotic Supplement
Dietary supplementThis intervention includes a combination of prebiotics and probiotics designed to promote vaginal and digestive health. The supplement contains Biotin, Lactobacillus acidophilus (as LA-14®), Bifidobacterium lactis (HN019™), Lactobacillus rhamnosus (as HN001™), Lactobacillus crispatus (as CCFM1110™), Lactobacillus gasseri (as HLG13™), Lactobacillus reuteri (as HR7™), Bacillus subtilis (as DE111®), PreforPro®, White Rice Flour, Magnesium Stearate (Vegetable Source), Silicon Dioxide (Bamboo Source), and Cellulose (Vegetable Capsule). Participants take two capsules daily with food for 30 days.
Active Placebo Supplement
Dietary supplementThe active placebo supplement contains similar probiotic strains without the prebiotic component. Ingredients include Biotin, Lactobacillus acidophilus, Bifidobacterium lactis, Lactobacillus rhamnosus, Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus reuteri, Bacillus subtilis, Inulin (from Chicory Root), White Rice Flour, Magnesium Stearate (Vegetable Source), Silicon Dioxide (Bamboo Source), and Cellulose (Vegetable Capsule). Participants take two capsules daily with food for 30 days.
Excipient Placebo Supplement
Dietary supplementThe excipient placebo supplement contains no active ingredients related to prebiotics or probiotics. It includes White Rice Flour, Magnesium Stearate (Vegetable Source), and Cellulose (Vegetable Capsule). Participants take two capsules daily with food for 30 days.
Treatment groups
Trial outcomes
Primary outcomes
Change in Vaginal Microbiome
This outcome measures the change in vaginal microbiome parameters from Baseline to Day 30. The vaginal microbiome will be assessed using microbiome sequencing at both Baseline and Day 30.
Secondary outcomes
Change in Perceived Symptoms of Bacterial Vaginosis
This outcome measures the change in symptoms associated with bacterial vaginosis and yeast infections (e.g., itchiness, odor, abnormal discharge) as reported by participants through questionnaires.
Change in Perceived Symptoms of Yeast Infections
This outcome measures the change in symptoms associated with bacterial vaginosis and yeast infections (e.g., itchiness, odor, abnormal discharge) as reported by participants through questionnaires.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Happy V
Lead sponsor
Citruslabs
Collaborator
This trial is not recruiting at the moment. You can still explore other options: